Save on this program with an Individual Membership
With a yearly Individual Membership, you get:
- On-Demand Learning
- Live Webcasts and Groupcasts
- 400 PLI and SEC Institute Forums
-
Interactive Learning Center Programs

On-Demand
Join us for an in-depth exploration of Generalized Cost-Effectiveness Analysis (GCEA), a groundbreaking approach that expands traditional value assessment in healthcare. This presentation will examine how GCEA incorporates broader societal impacts and equity considerations into healthcare decision-making, with particular relevance to Medicare drug pricing negotiations under the Inflation Reduction Act.
Discussion topics include:
Who Should Attend: Healthcare attorneys and legal professionals; Policy makers and regulatory advisors; Healthcare administrators and decision makers; Pharmaceutical industry professionals; Health technology assessment specialists; Healthcare consultants and analysts; Public health professionals interested in value assessment methodologies
Program Level: Update
Prerequisites: None
Advanced Preparation: None
Faculty:
Jason Shafrin, Ph.D.
FTI Consulting, Inc.
University of Southern California
Catherine Y. Starks
Sidley Austin LLP
Melanie Whittington, PhD
Tufts Medical Center
You must add a license in order to access your credit details and see approval status for this program.
With a yearly Individual Membership, you get: